NIH TETRAMER CORE FACILITY (HIV/AIDS)

国家过敏和传染病研究所（NIAID）支持对免疫反应的基本理解的研究，从而开发疫苗和新型治疗剂，用于预防和治疗传染病和免疫介导的疾病，并改善公共卫生。这项研究包括支持各种试剂设施，储存库和数据库，为生物医学研究人员提供资源。作为研究计划的一部分，以提高我们对传染病和免疫介导疾病的进展，预防和治疗的理解，NIAID支持NIH主要组织相容性复合物（MHC）四聚体核心设施。该设施为全球研究界提供可溶性MHC四聚体试剂的合成和分销。

The National Institute of Allergy and Infectious Diseases (NIAID) supports research on the basic understanding of immune responses leading to the development of vaccines and novel therapeutic agents for the prevention and treatment of infectious and immune-mediated diseases, and improvements in public health. This research includes support of various reagent facilities, repositories, and databases that provide resources for biomedical researchers. As a part of the research program to improve our understanding of the progression, prevention, and treatment of infectious and immune-mediated diseases, the NIAID supports the NIH Major Histocompatibility Complex (MHC) Tetramer Core Facility. This facility provides synthesis and distribution of soluble MHC tetramer reagents to the global research community.